adaptive(US) | $7,000,000 | (Apr 23, 2025)
Tally(US) | $8,000,000 | (Apr 23, 2025)
Recce | $4,000,000 | (Apr 23, 2025) Certified by Founder
Lodge
BioLoomics, Inc.
start up
United States
- Boulder, CO
- 20/09/2023
- Seed
- $8,700,000
BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML.
#synbio #directedevolution #antibodies
- Industry Biotechnology Research
- Website https://www.bioloomics.com/
- LinkedIn https://www.linkedin.com/company/bioloomics/about/
GreenFi | $17,000,000 | (Apr 23, 2025)
UbiQD, Inc. | $20,000,000 | (Apr 23, 2025)
Spur | $4,500,000 | (Apr 22, 2025)
Capsule | $12,000,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
Electra.aero | $115,000,000 | (Apr 22, 2025)